Drugs that contain Betamethasone Dipropionate

1. List of Sernivo drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9775851 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9364485 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9655907 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US10179137 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9433630 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9877974 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

US9439911 PRIMUS PHARMS Topical formulations comprising a steroid
Aug, 2030

(7 years from now)

Market Authorisation Date: 05 February, 2016

Treatment: Treatment of plaque psoriasis

Dosage: SPRAY;TOPICAL

How can I launch a generic of SERNIVO before it's patent expiration?
More Information on Dosage

SERNIVO family patents

15

United States

2

European Union

1

Denmark

1

India

1

Spain

1

Japan

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic